146 related articles for article (PubMed ID: 6947115)
21. [Tumor immunity induced by local radiotherapy].
Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
[TBL] [Abstract][Full Text] [Related]
22. Elimination of tumor-enhancing cells by cyclophosphamide and its relevance to cyclophosphamide therapy of the murine mammary tumor.
Nakajima H; Abe S; Masuko Y; Tsubouchi J; Yamazaki M; Mizuno D
Gan; 1981 Oct; 72(5):723-31. PubMed ID: 7327373
[TBL] [Abstract][Full Text] [Related]
23. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice.
Larsen FS; Spärck JV
Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):323-33. PubMed ID: 6229132
[TBL] [Abstract][Full Text] [Related]
24. [Suppressive cells induced by cyclophosphamide in the spleen of C3H mice].
Poupon MF; Kolb JP; Lespinats G
Ann Immunol (Paris); 1977; 128(1-2):283-4. PubMed ID: 848886
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
Andrade-Mena CE
Int J Tissue React; 1994; 16(2):95-103. PubMed ID: 7960506
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
Jurin M; Suit HD
Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
[No Abstract] [Full Text] [Related]
27. Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice.
Forni G; Cerruti Sola S; Giovarelli M; Santoni A; Martinetto P; Vietti D
J Natl Cancer Inst; 1986 Mar; 76(3):527-33. PubMed ID: 3081748
[TBL] [Abstract][Full Text] [Related]
28. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses.
Kao SF; Kuo HL; Lee YC; Chiang HC; Lin YS
Anticancer Res; 1994; 14(6B):2439-43. PubMed ID: 7872664
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
30. Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes.
Akiyama J; Kawamura T; Gotohda E; Yamada Y; Hosokawa M; Kodama T; Kobayashi H
Cancer Res; 1977 Sep; 37(9):3042-5. PubMed ID: 884662
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclophosphamide on the lymphoid tissues and humoral and cellular immune responsiveness of young calves.
Corrier DE; Adams LG; Pierce KR
Am J Vet Res; 1979 Dec; 40(12):1683-9. PubMed ID: 118689
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
Yamamoto S; Higuchi Y; Teshima H
Immunology; 1982 Sep; 47(1):31-40. PubMed ID: 7118162
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
34. Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.
Naito K; Oka T; Nomi S; Yamagishi H; Kahan BD
Jpn J Cancer Res; 1989 Nov; 80(11):1119-26. PubMed ID: 2514172
[TBL] [Abstract][Full Text] [Related]
35. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
Macek CM; Kahan BD; Pellis NR
J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
Zier KS; Salvadori S; Cronin KC; Gansbacher B
Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
[TBL] [Abstract][Full Text] [Related]
37. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM; Botsmanov KV
Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
[No Abstract] [Full Text] [Related]
38. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
Hernández-Caselles T; Stutman O
J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
[TBL] [Abstract][Full Text] [Related]
39. [Effect of fosfomycin on cellular immune reactions as affected by cyclophosphamide or corticosteroids].
Gillissen G; Breuer-Werle M; Ostendorp H
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):731-4. PubMed ID: 3054757
[TBL] [Abstract][Full Text] [Related]
40. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
